{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:31:41Z","timestamp":1787761901286,"version":"build-2784847793"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7]]},"abstract":"\n Background:<\/jats:title>\n Given the complexity of stroke, diverse mechanisms are known to be involved in its pathophysiology among which inflammation is one of the major culprits. Poor clinical outcomes are seen in those stroke patients with significant systemic inflammation. Therapeutic options to fight stroke are still limited and the only approved drug is tissue-plasminogen activator and\/or mechanical thrombectomy. As inflammation highly influences susceptibility of stroke patients to overcome the disease, there is an increasing need to develop new diagnostic, prognostic, and therapeutic strategies for poststroke inflammation.<\/jats:p>\n <\/jats:sec>\n \n Subjects and Methods:<\/jats:title>\n This study was conducted over a period of 18 months. Seventy-five patients who were diagnosed with acute ischemic stroke based on patient\u2019s clinical history, neurological signs, and radioimaging were included. Patients underwent computed tomography scan\/magnetic resonance imaging scan within 24 h of admission to exclude stroke mimics and primary intracerebral hemorrhage. National Institutes of Health Stroke Scale (NIHSS) was used to assess the severity of stroke clinically. Inflammatory biomarkers such as plasma MMP-9, high-sensitivity C-reactive protein (hs-CRP), interleukin-6 (IL-6), and S100B were measured using the ELISA kits.<\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n \n We observed that plasma concentration of MMP-9, IL-6, and S100B showed statistical significant association with severity of stroke as assessed by NIHSS, with Chi-square test values of \u03c7\n 2<\/jats:sup>\n = 24.69 for IL-6 (\n P<\/jats:italic>\n = 0.00), \u03c7\n 2<\/jats:sup>\n = 11.91 for S100B (\n P<\/jats:italic>\n = 0.008), and \u03c7\n 2<\/jats:sup>\n = 19.5 for MMP-9 (\n P<\/jats:italic>\n = 0.00). The mean values of MMP-9, IL-6, S100B levels, and hs-CRP levels were significantly elevated in severe, moderately to severe stroke groups as related with mild stroke group as evaluated by NIHSS.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion:<\/jats:title>\n Neuroinflammatory markers such as MMP-9, IL-6, S100B, and hs-CRP are the promising tool as inflammatory biomarkers with other indicators of acute ischemic injury to diagnose acute ischemic stroke and facilitate a better clinical assessment of patients during the acute phase of the disease. More importantly, this study showed that these biomarkers have strong independent prediction values for stroke outcome. We propose that some of those biomarkers might turn out to be targets to be therapeutically altered overcoming the urgent need for the identification of potent drugs to modulate stroke-associated inflammation.<\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/aam.aam_78_24","type":"journal-article","created":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T01:00:44Z","timestamp":1743555644000},"page":"567-572","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Clinical and Radiological Evaluation of Severity of Acute Ischemic Stroke with Special Reference to Neuroinflammatory Biomarkers"],"prefix":"10.4103","volume":"24","author":[{"given":"K C","family":"Shashidhara","sequence":"first","affiliation":[{"name":"Department of General Medicine, JSS Medical College and Hospital, JSSAHER, Mysuru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashika Reddy","family":"Padamati","sequence":"additional","affiliation":[{"name":"Department of General Medicine, CMC Vellore, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Manthappa","sequence":"additional","affiliation":[{"name":"Department of General Medicine, JSS Medical College and Hospital, JSSAHER, Mysuru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M C","family":"Prasad","sequence":"additional","affiliation":[{"name":"Department of General Medicine, JSS Medical College and Hospital, JSSAHER, Mysuru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,4,1]]},"reference":[{"key":"R1-20260422","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1161\/01.STR.20.10.1407","article-title":"Recommendations on stroke prevention, diagnosis, and therapy. Report of the WHO task force on stroke and other cerebrovascular disorders","volume":"20","author":"Goldstein","year":"1989","journal-title":"Stroke"},{"key":"R2-20260422","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S1474-4422(19)30034-1","article-title":"Global, regional, and national burden of stroke, 1990\u20132016: A systematic analysis for the global burden of disease study 2016","volume":"18","year":"2019","journal-title":"Lancet Neurol"},{"key":"R3-20260422","doi-asserted-by":"crossref","first-page":"175","DOI":"10.4103\/ijmr.IJMR_516_15","article-title":"Incidence & prevalence of stroke in India: A systematic review","volume":"146","author":"Kamalakannan","year":"2017","journal-title":"Indian J Med Res"},{"key":"R4-20260422","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1016\/S0140-6736(12)62134-5","article-title":"GBD 2010: A multi-investigator collaboration for global comparative descriptive epidemiology","volume":"380","author":"Murray","year":"2012","journal-title":"Lancet"},{"key":"R5-20260422","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/NRL.0b013e31815c666b","article-title":"The role of uric acid in stroke: The issue remains unresolved","volume":"14","author":"Dimitroula","year":"2008","journal-title":"Neurologist"},{"key":"R6-20260422","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000054789","article-title":"Estimation of mortality and morbidity due to strokes in India","volume":"20","author":"Anand","year":"2001","journal-title":"Neuroepidemiology"},{"key":"R7-20260422","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1161\/CIRCULATIONAHA.109.192278","article-title":"Criteria for evaluation of novel markers of cardiovascular risk: A scientific statement from the American Heart Association","volume":"119","author":"Hlatky","year":"2009","journal-title":"Circulation"},{"key":"R8-20260422","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1161\/STROKEAHA.107.511261","article-title":"Blood biomarkers in the diagnosis of ischemic stroke: A systematic review","volume":"39","author":"Whiteley","year":"2008","journal-title":"Stroke"},{"key":"R9-20260422","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1161\/STROKEAHA.117.017076","article-title":"Blood biomarkers for the early diagnosis of stroke: The stroke-chip study","volume":"48","author":"Bustamante","year":"2017","journal-title":"Stroke"},{"key":"R10-20260422","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1161\/01.STR.0000105927.62344.4C","article-title":"Novel diagnostic test for acute stroke","volume":"35","author":"Lynch","year":"2004","journal-title":"Stroke"},{"key":"R11-20260422","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.2147\/NDT.S67665","article-title":"High-sensitivity C-reactive protein, lipoprotein-related phospholipase A2, and acute ischemic stroke","volume":"10","author":"Kara","year":"2014","journal-title":"Neuropsychiatr Dis Treat"},{"key":"R12-20260422","doi-asserted-by":"crossref","first-page":"277","DOI":"10.14740\/jnr362w","article-title":"The role of D-dimer, fibrinogen and C-reactive protein as plasma biomarkers in acute ischemic stroke","volume":"5","author":"Melake","year":"2016","journal-title":"J Neurol Res"},{"key":"R13-20260422","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jns.2015.03.032","article-title":"Serum levels of procalcitonin and high sensitivity C-reactive protein are associated with long-term mortality in acute ischemic stroke","volume":"352","author":"Li","year":"2015","journal-title":"J Neurol Sci"},{"key":"R14-20260422","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1161\/STROKEAHA.113.002289","article-title":"High-sensitivity C-reactive protein and interleukin-6-dominant inflammation and ischemic stroke risk: The Northern Manhattan study","volume":"45","author":"Luna","year":"2014","journal-title":"Stroke"},{"key":"R15-20260422","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1161\/STROKEAHA.109.552802","article-title":"High-sensitivity C-reactive protein and lipoprotein-associated phospholipase A2 stability before and after stroke and myocardial infarction","volume":"40","author":"Elkind","year":"2009","journal-title":"Stroke"},{"key":"R16-20260422","first-page":"70","article-title":"Interleukin-6, a reliable prognostic factor for ischemic stroke","volume":"13","author":"Shaafi","year":"2014","journal-title":"Iran J Neurol"},{"key":"R17-20260422","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1159\/000486916","article-title":"Upregulated serum MiR-146b serves as a biomarker for acute ischemic stroke","volume":"45","author":"Chen","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"R18-20260422","doi-asserted-by":"crossref","first-page":"395","DOI":"10.5152\/npa.2014.7213","article-title":"The relationship of serum S100B levels with infarction size and clinical outcome in acute ischemic stroke patients","volume":"51","author":"Sel\u00e7uk","year":"2014","journal-title":"Noro Psikiyatr Ars"},{"key":"R19-20260422","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s41983-019-0105-8","article-title":"The role of S100B as a predictor of the functional outcome in geriatric patients with acute cerebrovascular stroke","volume":"55","author":"Abdel-Ghaffar","year":"2019","journal-title":"Egypt J Neurol Psychiatry Neurosurg"},{"key":"R20-20260422","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1212\/WNL.0000000000004257","article-title":"Serum matrix metalloproteinase-9 levels and prognosis of acute ischemic stroke","volume":"89","author":"Zhong","year":"2017","journal-title":"Neurology"}],"container-title":["Annals of African Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/aam.aam_78_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:07:26Z","timestamp":1787760446000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/aam.aam_78_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,1]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/aam.aam_78_24","relation":{},"ISSN":["1596-3519","0975-5764"],"issn-type":[{"value":"1596-3519","type":"print"},{"value":"0975-5764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,1]]},"assertion":[{"value":"2024-05-13","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-23","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}